BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1040 related articles for article (PubMed ID: 22818074)

  • 21. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial.
    Mack MJ; Leon MB; Smith CR; Miller DC; Moses JW; Tuzcu EM; Webb JG; Douglas PS; Anderson WN; Blackstone EH; Kodali SK; Makkar RR; Fontana GP; Kapadia S; Bavaria J; Hahn RT; Thourani VH; Babaliaros V; Pichard A; Herrmann HC; Brown DL; Williams M; Akin J; Davidson MJ; Svensson LG;
    Lancet; 2015 Jun; 385(9986):2477-84. PubMed ID: 25788234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients.
    Kleiman NS; Van Mieghem NM; Reardon MJ; Gada H; Mumtaz M; Olsen PS; Heiser J; Merhi W; Chetcuti S; Deeb GM; Chawla A; Kiaii B; Teefy P; Chu MWA; Yakubov SJ; Windecker S; Althouse AD; Baron SJ
    JACC Cardiovasc Interv; 2024 Apr; 17(8):979-988. PubMed ID: 38658126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of life in high-risk patients: comparison of transcatheter aortic valve implantation with surgical aortic valve replacement.
    Amonn K; Stortecky S; Brinks H; Gahl B; Windecker S; Wenaweser P; Carrel T; Huber C
    Eur J Cardiothorac Surg; 2013 Jan; 43(1):34-41; discussion 41-2. PubMed ID: 22531274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis.
    Simons CT; Cipriano LE; Shah RU; Garber AM; Owens DK; Hlatky MA
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):419-28. PubMed ID: 23838104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A.
    Barbanti M; Webb JG; Hahn RT; Feldman T; Boone RH; Smith CR; Kodali S; Zajarias A; Thompson CR; Green P; Babaliaros V; Makkar RR; Szeto WY; Douglas PS; McAndrew T; Hueter I; Miller DC; Leon MB;
    Circulation; 2013 Dec; 128(25):2776-84. PubMed ID: 24152861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes after transfemoral transcatheter aortic valve replacement: a comparison of the randomized PARTNER (Placement of AoRTic TraNscathetER Valves) trial with the NRCA (Nonrandomized Continued Access) registry.
    Fearon WF; Kodali S; Doshi D; Fischbein MP; Yeung AC; Tuzcu EM; Rihal CS; Babaliaros V; Zajarias A; Herrmann HC; Brown DL; Mack M; Teirstein PS; Whisenant BK; Makkar R; Kapadia S; Leon MB;
    JACC Cardiovasc Interv; 2014 Nov; 7(11):1245-51. PubMed ID: 25459036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transapical aortic valve replacement for severe aortic stenosis: results from the nonrandomized continued access cohort of the PARTNER trial.
    Dewey TM; Bowers B; Thourani VH; Babaliaros V; Smith CR; Leon MB; Svensson LG; Tuzcu EM; Miller DC; Teirstein PS; Tyner J; Brown DL; Fontana GP; Makkar RR; Williams MR; George I; Kirtane AJ; Bavaria JE; Mack MJ
    Ann Thorac Surg; 2013 Dec; 96(6):2083-9. PubMed ID: 23968764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcatheter versus surgical aortic-valve replacement in high-risk patients.
    Smith CR; Leon MB; Mack MJ; Miller DC; Moses JW; Svensson LG; Tuzcu EM; Webb JG; Fontana GP; Makkar RR; Williams M; Dewey T; Kapadia S; Babaliaros V; Thourani VH; Corso P; Pichard AD; Bavaria JE; Herrmann HC; Akin JJ; Anderson WN; Wang D; Pocock SJ;
    N Engl J Med; 2011 Jun; 364(23):2187-98. PubMed ID: 21639811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of varying degrees of renal dysfunction on transcatheter and surgical aortic valve replacement.
    Nguyen TC; Babaliaros VC; Razavi SA; Kilgo PD; Guyton RA; Devireddy CM; Shults CC; Mavromatis K; Kanitkar M; Block P; Lerakis S; Thourani VH
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1399-406; discussion 13406-7. PubMed ID: 24075566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy.
    Blackstone EH; Suri RM; Rajeswaran J; Babaliaros V; Douglas PS; Fearon WF; Miller DC; Hahn RT; Kapadia S; Kirtane AJ; Kodali SK; Mack M; Szeto WY; Thourani VH; Tuzcu EM; Williams MR; Akin JJ; Leon MB; Svensson LG
    Circulation; 2015 Jun; 131(22):1989-2000. PubMed ID: 25832034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery.
    Popma JJ; Adams DH; Reardon MJ; Yakubov SJ; Kleiman NS; Heimansohn D; Hermiller J; Hughes GC; Harrison JK; Coselli J; Diez J; Kafi A; Schreiber T; Gleason TG; Conte J; Buchbinder M; Deeb GM; Carabello B; Serruys PW; Chenoweth S; Oh JK;
    J Am Coll Cardiol; 2014 May; 63(19):1972-81. PubMed ID: 24657695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Durability of quality of life benefits of transcatheter aortic valve replacement: Long-term results from the CoreValve US extreme risk trial.
    Baron SJ; Arnold SV; Reynolds MR; Wang K; Deeb M; Reardon MJ; Hermiller J; Yakubov SJ; Adams DH; Popma JJ; Cohen DJ;
    Am Heart J; 2017 Dec; 194():39-48. PubMed ID: 29223434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial.
    Thyregod HG; Steinbrüchel DA; Ihlemann N; Nissen H; Kjeldsen BJ; Petursson P; Chang Y; Franzen OW; Engstrøm T; Clemmensen P; Hansen PB; Andersen LW; Olsen PS; Søndergaard L
    J Am Coll Cardiol; 2015 May; 65(20):2184-94. PubMed ID: 25787196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry.
    Eltchaninoff H; Prat A; Gilard M; Leguerrier A; Blanchard D; Fournial G; Iung B; Donzeau-Gouge P; Tribouilloy C; Debrux JL; Pavie A; Gueret P;
    Eur Heart J; 2011 Jan; 32(2):191-7. PubMed ID: 20843959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How to define a poor outcome after transcatheter aortic valve replacement: conceptual framework and empirical observations from the placement of aortic transcatheter valve (PARTNER) trial.
    Arnold SV; Spertus JA; Lei Y; Green P; Kirtane AJ; Kapadia S; Thourani VH; Herrmann HC; Beohar N; Zajarias A; Mack MJ; Leon MB; Cohen DJ
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):591-7. PubMed ID: 24021691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concomitant percutaneous coronary intervention and transcatheter aortic valve replacement: safe and feasible replacement alternative approaches in high-risk patients with severe aortic stenosis and coronary artery disease.
    Salhab KF; Al Kindi AH; Lane JH; Knudson KE; Kapadia S; Roselli EE; Tuzcu ME; Svensson LG
    J Card Surg; 2013 Sep; 28(5):481-3. PubMed ID: 23869423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcatheter aortic valve implantation (TAVI): first case in Thailand.
    Sakiyalak P; Slisatkorn W; Pornratanarangsi S; Wongpraparut N; Jakrapanichakul D; Raksamani K; Prakanrattana U; Laksanabunsong P
    J Med Assoc Thai; 2012 Jan; 95(1):124-8. PubMed ID: 22379752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two-year outcomes after transcatheter or surgical aortic-valve replacement.
    Kodali SK; Williams MR; Smith CR; Svensson LG; Webb JG; Makkar RR; Fontana GP; Dewey TM; Thourani VH; Pichard AD; Fischbein M; Szeto WY; Lim S; Greason KL; Teirstein PS; Malaisrie SC; Douglas PS; Hahn RT; Whisenant B; Zajarias A; Wang D; Akin JJ; Anderson WN; Leon MB;
    N Engl J Med; 2012 May; 366(18):1686-95. PubMed ID: 22443479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER Trial.
    Kapadia SR; Huded CP; Kodali SK; Svensson LG; Tuzcu EM; Baron SJ; Cohen DJ; Miller DC; Thourani VH; Herrmann HC; Mack MJ; Szerlip M; Makkar RR; Webb JG; Smith CR; Rajeswaran J; Blackstone EH; Leon MB;
    J Am Coll Cardiol; 2018 Nov; 72(20):2415-2426. PubMed ID: 30442284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis: a Placement of Aortic Transcatheter Valves (PARTNER) trial analysis.
    Herrmann HC; Pibarot P; Hueter I; Gertz ZM; Stewart WJ; Kapadia S; Tuzcu EM; Babaliaros V; Thourani V; Szeto WY; Bavaria JE; Kodali S; Hahn RT; Williams M; Miller DC; Douglas PS; Leon MB
    Circulation; 2013 Jun; 127(23):2316-26. PubMed ID: 23661722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.